New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia

Within the past 3 years, the FDA has approved five new treatment options for patients with CLL. While these advances improve patient outcomes and the quality of care, there is a need for advanced practitioners to stay up to date and informed in order to translate these advances into the clinical set...

Descripción completa

Detalles Bibliográficos
Autores principales: Moran, Mollie, Jones, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003763/
https://www.ncbi.nlm.nih.gov/pubmed/29928551
_version_ 1783332406805135360
author Moran, Mollie
Jones, Jeffrey
author_facet Moran, Mollie
Jones, Jeffrey
author_sort Moran, Mollie
collection PubMed
description Within the past 3 years, the FDA has approved five new treatment options for patients with CLL. While these advances improve patient outcomes and the quality of care, there is a need for advanced practitioners to stay up to date and informed in order to translate these advances into the clinical setting.
format Online
Article
Text
id pubmed-6003763
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-60037632018-06-20 New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia Moran, Mollie Jones, Jeffrey J Adv Pract Oncol Review Article Within the past 3 years, the FDA has approved five new treatment options for patients with CLL. While these advances improve patient outcomes and the quality of care, there is a need for advanced practitioners to stay up to date and informed in order to translate these advances into the clinical setting. Harborside Press 2017-04 2017-04-01 /pmc/articles/PMC6003763/ /pubmed/29928551 Text en Copyright © 2017, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Moran, Mollie
Jones, Jeffrey
New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
title New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
title_full New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
title_fullStr New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
title_full_unstemmed New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
title_short New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia
title_sort new treatment paradigms defined for chronic lymphocytic leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003763/
https://www.ncbi.nlm.nih.gov/pubmed/29928551
work_keys_str_mv AT moranmollie newtreatmentparadigmsdefinedforchroniclymphocyticleukemia
AT jonesjeffrey newtreatmentparadigmsdefinedforchroniclymphocyticleukemia

Ejemplares similares